# Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

Study · id `cardio:ct-nct04452149` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04452149](<https://clinicaltrials.gov/study/NCT04452149>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04452149

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 826 participants.

## Technical summary

Registry record NCT04452149. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-03 (actual); primary completion 2025-06-02 (actual). Results posted on 2026-08-26.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 826 participants (enrolled count; ClinicalTrials.gov record NCT04452149, source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)
- Started: 2020-09-03 (actual) (ClinicalTrials.gov record NCT04452149, source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)
- Primary completion: 2025-06-02 (actual) (ClinicalTrials.gov record NCT04452149, source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)
- Completion: 2025-06-02 (actual) (ClinicalTrials.gov record NCT04452149, source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)
- Results first posted: 2026-08-26 (ClinicalTrials.gov record NCT04452149, source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04452149, source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04452149-2026-08-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
- Acronym: ALLEVIATE-HF
- Condition: Heart Failure NYHA Class II
- Condition: Heart Failure NYHA Class III
- Intervention (Device): Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download
- Intervention (Other): Medication intervention
- Intervention (Other): Not Randomized to Device or Medication Intervention
- Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial (`cardio:pubmed-42201276`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial (`cardio:pubmed-42201288`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3d4e50bf5ea4fb18c519230a74c2e06ddb37926421f3f56e8c689a9fc134cb8b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
